Tesamorelin, a synthetic molecule, represents a emerging therapy primarily prescribed for addressing intra-abdominal fat build-up in individuals experiencing HIV. This targeted medication functions to the natural production of growth hormone-releasing , which, in turn , can assist to diminishing fat amounts and potentially enhancing overall heal… Read More


A notable advancement in diabetes treatment is emerging with the approval of tirzepatide at a dosage of 45mg. This updated version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and delivers a potentially enhanced advantage for individuals with diabetes of type 2. Clinical research have showed that the higher dos… Read More